The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIOMED INC | COM | 003654100 | 163,764 | 494,397 | SH | SOLE | 494,397 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 54,539 | 2,251,834 | SH | SOLE | 2,251,834 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 715 | 160,800 | SH | SOLE | 160,800 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 19,317 | 44,305 | SH | SOLE | 44,305 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259202 | 1,125 | 200,919 | SH | SOLE | 200,919 | 0 | 0 | ||
ALKERMES PLC | COM | G01767105 | 17,722 | 673,571 | SH | SOLE | 673,571 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 93,789 | 9,903,761 | SH | SOLE | 9,903,761 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 10,664 | 431,024 | SH | SOLE | 431,024 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 76,023 | 360,981 | SH | SOLE | 360,981 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 164,964 | 2,139,614 | SH | SOLE | 2,139,614 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 9,037 | 4,473,967 | SH | SOLE | 4,473,967 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 4,112 | 111,717 | SH | SOLE | 111,717 | 0 | 0 | ||
EHEALTH INC | COM | 28238P109 | 20,505 | 1,652,260 | SH | SOLE | 1,652,260 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 7,791 | 6,774,541 | SH | SOLE | 6,774,541 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 15,249 | 1,756,757 | SH | SOLE | 1,756,757 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 9,602 | 2,330,504 | SH | SOLE | 2,330,504 | 0 | 0 | ||
INSMED INC | COM | 457669307 | 138,211 | 5,881,299 | SH | SOLE | 5,881,299 | 0 | 0 | ||
KALEIDO BIOSCIENCES INC | COM | 483347100 | 511 | 309,692 | SH | SOLE | 309,692 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 41,431 | 5,621,533 | SH | SOLE | 5,621,533 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 10,906 | 656,200 | SH | SOLE | 656,200 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 1,254 | 432,300 | SH | SOLE | 432,300 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM | 56854Q200 | 293 | 31,330 | SH | SOLE | 31,330 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,425 | 64,700 | SH | SOLE | 64,700 | 0 | 0 | ||
NOVAVAX INC | COM | 670002401 | 921 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | ||
PROTHENA CORP PLC | COM | G72800108 | 61,492 | 1,681,477 | SH | SOLE | 1,681,477 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 86,106 | 4,415,689 | SH | SOLE | 4,415,689 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM | 766559603 | 1,951 | 652,395 | SH | SOLE | 652,395 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 28,192 | 851,719 | SH | SOLE | 851,719 | 0 | 0 | ||
STAAR SURGICAL CO | COM | 852312305 | 90,855 | 1,136,968 | SH | SOLE | 1,136,968 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 10,647 | 612,600 | SH | SOLE | 612,600 | 0 | 0 | ||
TACTILE SYSTEMS TECHNOLOGY I | COM | 87357P100 | 546 | 27,100 | SH | SOLE | 27,100 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 4,280 | 166,069 | SH | SOLE | 166,069 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 117,169 | 653,079 | SH | SOLE | 653,079 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 213 | 24,500 | SH | SOLE | 24,500 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 28,175 | 2,491,200 | SH | SOLE | 2,491,200 | 0 | 0 |